Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to determine posture and posture related factors in patients with restrictive and obstructive lung disease.
It is aimed at investigating posture and posture related factors according to both type of disease and severity of disease in patients with restrictive and obstructive lung disease. The secondary purpose is to develop a model that determines correlations between posture and functional exercise capacity, respiratory and peripheral muscle strength, tightness of muscle, balance, and physical activity for each disease that will be included in this study. In accordance with these purposes, for each group, at least 15 patients with obstructive and restrictive lung disease will be included according to the inclusion and exclusion criteria for each disease, and 15 healthy controls will be included. Tests and questionnaires will be used in order to determine the severity of diseases. Lung function test and respiratory and peripheral muscle strength test will be performed. Time and Go test (TUG) and One minute sit to stand test will be performed. To evaluate the accessory respiratory muscles, a muscle tightness test will be performed for each muscle. Six Minute Walk Test (6 MWT) will be performed with an armband that measures energy expenditure for functional exercise capacity. To evaluate posture, the Corbin Postural Assessment Scale and photographic analysis will be used. Photographical analysis using software in lateral, posterior, and anterior views will be used for the cervical, thoracic, and lumbar regions. For angular and length measurements, anatomical landmarks will be determined and calculated in the regions. According to the results to be obtained, changes in posture according to the regions and posture related factors will be determined for each disease. It will guide professional working in this field.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Patients with chronic obstructive lung disease, asthma, cystic fibrosis and bronchiectasis. | ||
| Group B | Patients with diffuse parenchymal lung diseases | ||
| control group | healthy aged matched individuals. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of horizontal alignment of the head anterior view | Angle between left and right tragus and horizontal will be measured via photographic analysis | 1 day |
| Evaluation of horizontal alignment of the trunk anterior view | Angle between left and right acromion and horizontal will be measured via photographic analysis Angle between left and right anterior superior iliac spine and horizontal will be measured via photographic analysis. Angle between left and right acromion and left and right anterior superior iliac spine will be measured via photographic analysis. | 1 day |
| Evaluation of horizontal alignment of the head lateral view | Angle between left-right tragus and C7 spinous process and horizontal will be measured via photographic analysis. | 1 day |
| Evaluation of vertical alignment of the head lateral view | Angle of acromion and tragus (left-right) and vertical will be measured via photographic analysis. | 1 day |
| Evaluation of horizontal alignment of the trunk lateral view | Angle between anterior superior iliac spine and posterior superior iliac spina and horizontal will be measured via photographic analysis. | 1 day |
| Evaluation of vertical alignment of the trunk lateral view | Angle between acromion and greater trochanter and vertical will be measured via photographic analysis. | 1 day |
| Evaluation of horizontal asymmetry trunk in posterior view |
| Measure | Description | Time Frame |
|---|---|---|
| Functional exercise capacity | Functional exercise capacity will be determined via Six Minute Walk Test. | 1 day |
| Respiratory Muscle Strength | Respiratory muscle strength will be assessed using a mouth pressure device according to American Thoracic Society/ European Respiratory Society guidelines. |
Not provided
Inclusion Criteria:
Chronic Obstructive Pulmonary Disease Group Inclusion Criteria:
Chronic Obstructive Pulmonary Disease Group Exclusion Criteria:
Inclusion Criteria for the Cystic Fibrosis Group:
Cystic Fibrosis Group Exclusion Criteria:
Inclusion Criteria for the Asthma Group:
Asthma Group Exclusion Criteria:
Inclusion Criteria for Bronchiectasis Group:
Bronchiectasis Group Exclusion Criteria:
Diffuse Parenchymal Lung Diseases Inclusion Criteria:
Diffuse Parenchymal Lung Diseases Exclusion Criteria:
Not provided
Not provided
Not provided
Obstructive and restrictive lung disease and healthy controls will be included in this study according to the inclusion and exclusion criteria.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Aynur Demirel, PhD | Contact | +905545295057 | aynur.demirel@hacettepe.edu.tr | |
| Hidaye Yamikan, PT,MSc | Contact | +905349898724 | hidaye.yamikan@hacettepe.edu.tr |
| Name | Affiliation | Role |
|---|---|---|
| Aynur Demirel | Hacettepe University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aynur Demirel | Ankara | 06100 | Turkey (Türkiye) | |||
| Hacettepe University |
Not provided
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| ID | Term |
|---|---|
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Horizontal asymmetry of scapula in relation to T3 spinous process will be measured via photographic analysis. |
| 1 day |
| Evaluation of scapulae | Investigation of posture by photographic analysis upward rotation/ anterior tilt/internal rotation of scapula, scapular elevation, and scapular abduction evaluations will be measured photographic analysis. | 1 day |
| Posture | Posture will be examined via the Corbin Postural Assessment Scale. The total points of the Corbin Postural Assessment Scale range from 0 to 28 points. A higher point represents worse posture. | 1 day |
| 1 day |
| Lung function | Lung function will be assessed via a spirometer according to American Thoracic Society/ European Respiratory Society guidelines. | 1 day |
| Dyspnea | Dyspnea will be assessed via The Modified Medical Research Council. The Modified Medical Research Council consists of five grades. A higher grades represents severe dyspnea level. | 1 day |
| Peripheral muscle strength | Peripheral muscle strength will be assessed via hand dynamometer. | 1 day |
| Lower extremity capacity | One minute sit to stand test will be used for lower extremity capacity. | 1 day |
| Energy expenditure | An armband will be used to assess energy expenditure during six minute walk test. | 1 day |
| Balance and Fall risk | Time up and go test will be used to assess balance and fall risk | 1 day |
| Tightness of muscle | Pectoralis minör, pectoralis majör, adductor and internal rotator muscles, sternocleidomastoideus, and trapezius muscle tightness tests will be performed during musculoskeletal examination using a tape. | 1 day |
| Severity of disease for patients with COPD | Global Initiative for Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Pulmonary A,B,E assessment Tool will be used for patients with COPD. According to the Global Initiative for Chronic Obstructive Pulmonary Disease, the severity of airflow limitation (Forced Expiratory Volume in 1 s) was determined as mild (≥ 80%), moderate (50-80%), severe (30-50%), and very severe (<30%). According to Global Initiative for Chronic Obstructive Pulmonary ABE assessment Tool, patients classified group A, B, and E using symptom status and airflow limitation. | 1 day |
| Severity of disease for patients with bronchiectasis | Patients with non- cystic fibrosis bronchiectasis will be classified into three groups according to the Forced Expiratory Volume in 1 s, Age, Chronic colonisation, Extension, Dyspnea level. According to this classification system, patients will be classified as 0-2 points mild, 3-4 moderate, 5-7 severe bronchiectasis. | 1 day |
| Diffusion capacity for patients with diffuse parenchymal lung diseases | Carbon Monoxide Diffusion Capacity test with single breath method will be used for patients with diffuse parenchymal lung diseases. | 1 day |
| Symptoms for patients with COPD | Chronic Obstructive Pulmonary Disease Assessment Test will be used to determined symptoms in patients with COPD. The total score of Chronic Obstructive Pulmonary Disease Assessment Test changes from 0 to 40 points, and 10 points is the accepted cut-off point for COPD. | 1 day |
| Ankara |
| 06100 |
| Turkey (Türkiye) |
|